An analysis of data from a large health plan database in the U.S. found that older men who took second-generation antipsychotic drugs risperidone or paliperidone were 69% more likely to develop gynecomastia than nonusers. The findings were presented at the annual meeting of the American Association for Geriatric Psychiatry.

Related Summaries